Giá của DelMar Pharmaceuticals, Inc. là bao nhiêu (DMPWW)

Giá của DelMar Pharmaceuticals, Inc. (DMPWW) là $0.005

Mũ thị trường của DelMar Pharmaceuticals, Inc. là gì (DMPWW)

Giới hạn thị trường của DelMar Pharmaceuticals, Inc. (DMPWW) là $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) EPS

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Năm	EPS	Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.

Năm

EPS

Thay đổi

Không đủ dữ liệu cho ngày được cung cấp.

Công ty	EPS	Chênh lệch EPS	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	$13.70	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Công ty

EPS

Chênh lệch EPS

Quốc gia